Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 019836

Expand all

SUPPRELIN (HISTRELIN ACETATE)
EQ 0.2MG BASE/ML
Marketing Status: Discontinued

Active Ingredient: HISTRELIN ACETATE
Proprietary Name: SUPPRELIN
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 0.2MG BASE/ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N019836
Product Number: 001
Approval Date: Dec 24, 1991
Applicant Holder Full Name: SHIRE DEVELOPMENT INC
Marketing Status:  Discontinued
Patent and Exclusivity Information

SUPPRELIN (HISTRELIN ACETATE)
EQ 0.5MG BASE/ML
Marketing Status: Discontinued

Active Ingredient: HISTRELIN ACETATE
Proprietary Name: SUPPRELIN
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 0.5MG BASE/ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N019836
Product Number: 002
Approval Date: Dec 24, 1991
Applicant Holder Full Name: SHIRE DEVELOPMENT INC
Marketing Status:  Discontinued
Patent and Exclusivity Information

SUPPRELIN (HISTRELIN ACETATE)
EQ 1MG BASE/ML
Marketing Status: Discontinued

Active Ingredient: HISTRELIN ACETATE
Proprietary Name: SUPPRELIN
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 1MG BASE/ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N019836
Product Number: 003
Approval Date: Dec 24, 1991
Applicant Holder Full Name: SHIRE DEVELOPMENT INC
Marketing Status:  Discontinued
Patent and Exclusivity Information